Granules India Limited has announced its financial results for the quarter ended June 30, 2025, showing modest revenue growth but a decline in profitability compared to the same period last year.
The pharmaceutical major posted revenue from operations of ₹1,210.11 crore in Q1 FY26, up 2.56% from ₹1,179.87 crore in Q1 FY25. Total income also rose 3.77% YoY to ₹1,226.45 crore.
However, expenses climbed 5.55% YoY to ₹1,056.02 crore, which weighed on margins. Profit before tax dropped 20.32% YoY to ₹144.53 crore.
Tax expenses for the quarter fell 31.74% YoY to ₹31.89 crore, but this was not enough to offset the overall profit decline. The company reported a net profit of ₹112.63 crore, down 16.37% from ₹134.65 crore in the same quarter last year.
In the meantime, on the market front, Granules India shares traded between ₹440.00 and ₹453.45 today, with an opening price of ₹442.55 and the previous close at ₹440.55. The stock’s 52-week range stands between ₹422.00 and ₹721.00.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
